key: cord-1029542-et4qsbz7 authors: Pettoello-Mantovani, Massimo; Carrasco-Sanz, Angel; Huss, Gottfried; Mestrovic, Julije; Vural, Mehmet; Pop, Tudor Lucian; Ferrara, Pietro; Somekh, Eli; Mujkic, Aida; Hoey, Hilary; Namazova-Baranova, Leyla title: Viewpoint of the European pediatric societies over SARS-CoV-2 Vaccination in Children under age 12 amid return to school and the surging virus variants. date: 2021-09-15 journal: J Pediatr DOI: 10.1016/j.jpeds.2021.09.013 sha: 3544c1c4eb72b88cf6d143a9c9b1534833a92bb6 doc_id: 1029542 cord_uid: et4qsbz7 nan Since its first appearance in the Wuhan region of China in December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a public health and a socio-economic crisis worldwide 1 Care Paediatricians (ECPCP), on SARS-CoV-2 vaccination in children under age 12. The aim is to raise awareness of pediatricians, lawmakers, public health officers, and school educators on the importance of extending vaccination after a careful risk assessment is made. We emphasize that proper and safe vaccination procedures should be initiated after satisfactory clinical trials are completed and following formal approval by public authorities 5 . These changes may affect the virus's properties, including ability of spreading, severity of associated diseases, and resistance to preventive and therapeutic measures 6 . The emergence of SARS-CoV-2 variants rapidly spreading worldwide pose an increased risk to global public health. In Europe, the delta variant, initially arose in the UK in April 2021 6 , and later became the dominant strain in the majority of the European countries. Currently, the classification developed by the World Health Organization to identify specific Variants of Interest (VOIs) and Variants of Concern (VOCs) helps to prioritize an effective global monitoring and research, to J o u r n a l P r e -p r o o f elaborate the development of public health guidance to prevent the spread of COVID-19, and ultimately to inform the ongoing response to the COVID-19 pandemic 6 (Table; available at www.jpeds.com). After the delta variant became the most dominant circulating strain, the number of children contracting COVID-19 has increased 7 . After the infection initially declined among children in early Summer 2021, the US and European countries showed an impressive five-fold increase of cases in this population. As reported by the American Academy of Pediatrics, during a four week period between July and August 2021, COVID-19 cases in children increased from 38,000 to nearly 204,000 and numerous states reported an increase, although moderate, in child hospitalizations amid the ongoing delta surge 7 . Similarly, a significant increase in COVID-19 cases is reported in Europe. In the UK, there has been a 5-fold higher rate of COVID-19 test positivity among children 5 to 12 years of age (0.35% prevalence) and adults ages 18 to 24 (0.36% prevalence) than in those 65 years of age or older 8 . Furthermore, of great concern is the increase of pediatric multisystem inflammatory syndrome (MIS-C) associated to COVID-19, which showed an incidence of about 100 affected children per week 9 . In Italy, the local national institute of health reports that after the emergence of the delta variant, the increase of COVID-19 cases involved the population 0-9 years old, while the older age groups showed a decline in cases 10 . In Israel, emerging data indicate a sharp rise in SARS-CoV-2 infections during the first months of 2021 in the population 0-9 and 10-19 with more than 50 000 children and teens testing positive 11 . The debate over the importance of COVID-19 vaccination in children under 12 rapidly arose after the emergence of aggressive virus variants. In this population, the number of infections sharply grew in parallel with the number of severe cases, which led to the hospitalization of young children 9 . In particular, the delta variant showed to be more contagious to children and from children than the older variants. SARS-CoV-2 may spread in schools, homes, and gatherings where kids typically can get infected most and although the virus has been less aggressive in children than adults, not all children have been immune to some severe health risks associated to the infection, including MIS-C 9 . Two main approaches may be considered in vaccine prioritization: directly vaccinate people at highest risk for severe outcomes and indirectly protect the weakest part of population by vaccinating those who do the most transmitting 12 . The experience provided by the influenza vaccination programs, which suggests that children are vaccinated due to their critical role in transmission 13,14 , J o u r n a l P r e -p r o o f shows that direct protection is superior when reproduction numbers are high, but indirect protection is greater when transmission is low 15 . The rationale behind vaccinating children under age12 would be not only to help the communities reach herd immunity, minimize viral transmission, and reduce the risk of development of virus variants, but also to protect this age group from the SARS-CoV-2 infection and disease. Vaccines undergo rigorous regulatory approval procedures to ensure their safety, efficacy, and quality 16 Pettoello-Mantovani M Children facing natural, economic and public health crisis in Europe: The risks of a predictable unpredictability. Turk Pediatri Ars World Health Organization. WHO Coronavirus (COVID-19) Dashboard Our World Data. Statistics and research: coronavirus (Covid-19) vaccinations Covid-19: Delta variant is now UK's most dominant strain and spreading through schools Integrating and rationalizing public healthcare services as a source of cost containment in times of economic crises World Health Organization. Tracking SARS-CoV-2 variants State-Level Data Report Delta variant behind UK COVID surge Acute covid-19 and multisystem inflammatory syndrome in children COVID-19 integrated surveillance: key national data Covid-19: More young children are being infected in Israel and Italy, emerging data suggest Model-informed COVID-19 vaccine prioritization strategies by age and serostatus Populationwide benefits of routine vaccination of children against influenza Optimizing influenza vaccine distribution A comparative analysis of influenza vaccination programs Elements of Regulatory Dissonance: Examining FDA and EMA Product Labeling of New Vaccines (2006-2018) American Academy of Pediatrics Cautions Against Off-Label Use of COVID-19 Vaccines in Children Under 12 European Medicines Agency. Covid-19 vaccines Under-12s are increasingly catching COVID-19. How sick are they getting and when will we be able to vaccinate them? BNT162b2 mRNA Covid Vaccine in a Nationwide Mass Vaccination Setting Fostering Resilience in Children: The Essential Role of Healthcare Professionals and Families Child Abuse and Neglect and its Psycho-Physical and Social Consequences: A Review of the Literature Number 1, Religious Education. Excerpt from "The Group Plan" by Rev. H. K. Williams in the "Young People's Service Participation of Children and Young People in Their Health Care: Understanding the Potential and Limitations GH/501Y.V2 20H (V2) +S:L18F South Africa GR/501Y.V3 20J (V3) +S:681H Brazil 417N India